Posted On: 09/02/2013 10:38:35 PM
Post# of 250679
RegeneRx Biopharmaceuticals, Inc. RGNXW Company Overview
Stock Message Board http://investorshangout.com/search?q=RGNXW&am...mp;yt1=Go!
RegeneRx Biopharmaceuticals, Inc. RGNXW Current Price and Quotes
0.01
Previous Close
0.01
Open
N/A
Daily Range
N/A - N/A
52wk Range
0.275 - 0.0002
Volume
0
Dividend
N/A
Average Vol (3m)
6,395
Yield
N/A
RegeneRx Biopharmaceuticals, Inc. RGNXW
Company Information
15245 Shady Grove Road
Suite 470
Rockville, MD 20850
Website: http://www.regenerx.com/wt/home/index
Phone: 301-208 9191
Email: info@regenerx.com
RegeneRx Biopharmaceuticals, Inc. RGNXW
RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company focused on tissue protection, repair and regeneration with an extensive portfolio of product candidates for first-in-class therapeutic peptides.
RegeneRx Biopharmaceuticals, Inc. RGNXW
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0000707511
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1995
Employees Not Available
Company Officers/Contacts
J.J. Finkelstein President, CEO
C. Neil Lyons CFO
Albert Rosenfeld Secretary
Company Directors
Not Available
Company Notes
Formerly=Alpha 1 Biomedicals, Inc. until 12-00
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
RegeneRx Biopharmaceuticals, Inc. RGNXW
RGNXW Security Details Other Company Securities
Share Structure
Market Value1 $115,000 a/o Aug 30, 2013
Shares Outstanding 11,500,000 a/o May 17, 2010
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders
Shareholders of Record 4,400 a/o Mar 31, 2010
Short Selling Data
Short Interest 0 (-100%)
Sep 30, 2011
Significant Failures to Deliver No
Transfer Agent(s)
RegeneRx Biopharmaceuticals, Inc. RGNXW Recent News
Jun 24, 2013 RegeneRx Releases Results of Phase 2 Clinical Trial on Patients with Epidermolysis Bullosa
RegeneRx Biopharmaceuticals, Inc. RGNXW Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 1,343 1,512 850 -
Cost of Revenue - - - -
Gross Profit 1,343 1,512 850 -
Operating Expenses
Research and Development 1,162 5,067 2,708 3,725
Sales, General and Admin. 1,022 2,456 3,174 2,782
Non-Recurring Items - - - -
Other - - - -
Operating Income (841) (6,012) (5,032) (6,506)
Income From Continuing Operations
Add'l Income/Expense Items - 4 8 12
Earnings Before Interest and Tax (841) (6,007) (5,024) (6,494)
Interest Expense 6 - - -
Earnings Before Tax (847) (6,007) (5,024) (6,494)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (847) (6,007) (5,024) (6,494)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (847) (6,007) (5,024) (6,494)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (847) (6,007) (5,024) (6,494)
RGNXW RegeneRx Biopharmaceuticals, Inc. Research DD Guide
RGNXW RegeneRx Biopharmaceuticals, Inc. Stock Message Board http://investorshangout.com/search?q=RGNXW&am...mp;yt0=Go!
RGNXW RegeneRx Biopharmaceuticals, Inc. Stock Quote http://www.otcmarkets.com/stock/RGNXW/quote
RGNXW RegeneRx Biopharmaceuticals, Inc. Stock Chart http://www.otcmarkets.com/stock/RGNXW/chart
RGNXW RegeneRx Biopharmaceuticals, Inc. Company Info http://www.otcmarkets.com/stock/RGNXW/company-info
RGNXW RegeneRx Biopharmaceuticals, Inc. Recent News http://www.otcmarkets.com/stock/RGNXW/news
RGNXW RegeneRx Biopharmaceuticals, Inc. Financials http://www.otcmarkets.com/stock/RGNXW/financials
RGNXW RegeneRx Biopharmaceuticals, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/RGNXW/filings
RGNXW RegeneRx Biopharmaceuticals, Inc. Short Sales http://www.otcmarkets.com/stock/RGNXW/short-sales
RGNXW RegeneRx Biopharmaceuticals, Inc. Insider Disclosure http://www.otcmarkets.com/stock/RGNXW/insider-transactions
RGNXW RegeneRx Biopharmaceuticals, Inc. Research Reports http://www.otcmarkets.com/stock/RGNXW/research
RGNXW RegeneRx Biopharmaceuticals, Inc. Summary http://finance.yahoo.com/q?s=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=RGNXW+Historical+Prices
RGNXW RegeneRx Biopharmaceuticals, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=RGNXW+Basic+Chart
RGNXW RegeneRx Biopharmaceuticals, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=RGNXW+Basic+Tech.+Analysis
RGNXW RegeneRx Biopharmaceuticals, Inc. Headlines http://finance.yahoo.com/q/h?s=RGNXW+Headlines
RGNXW RegeneRx Biopharmaceuticals, Inc. Press Releases http://finance.yahoo.com/q/p?s=RGNXW+Press+Releases
RGNXW RegeneRx Biopharmaceuticals, Inc. Company Profile http://finance.yahoo.com/q/pr?s=RGNXW+Profile
RGNXW RegeneRx Biopharmaceuticals, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=RGNXW+Key+Statistics
RGNXW RegeneRx Biopharmaceuticals, Inc. Industry http://finance.yahoo.com/q/in?s=RGNXW+Industry
RGNXW RegeneRx Biopharmaceuticals, Inc. Major Holders http://finance.yahoo.com/q/mh?s=RGNXW+Major+Holders
RGNXW RegeneRx Biopharmaceuticals, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=RGNXW+Insider+Transactions
RGNXW RegeneRx Biopharmaceuticals, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=RGNXW+Insider+Roster
RGNXW RegeneRx Biopharmaceuticals, Inc. Income Statement http://finance.yahoo.com/q/is?s=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=RGNXW+Cash+Flow&annual
RGNXW RegeneRx Biopharmaceuticals, Inc. Nasdaq http://www.nasdaq.com/symbol/RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Market Watch http://www.marketwatch.com/investing/stock/RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Bloomberg http://www.bloomberg.com/quote/RGNXW:US
RGNXW RegeneRx Biopharmaceuticals, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Bussinessweek http://investing.businessweek.com/research/st...cker=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Barchart http://www.barchart.com/quotes/stocks/RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. OTC Short Report http://otcshortreport.com/index.php?index=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Investopedia http://www.investopedia.com/markets/stocks/RGNXW/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Stock Message Board http://investorshangout.com/search?q=RGNXW&am...mp;yt1=Go!
RegeneRx Biopharmaceuticals, Inc. RGNXW Current Price and Quotes
0.01
Previous Close
0.01
Open
N/A
Daily Range
N/A - N/A
52wk Range
0.275 - 0.0002
Volume
0
Dividend
N/A
Average Vol (3m)
6,395
Yield
N/A
RegeneRx Biopharmaceuticals, Inc. RGNXW
Company Information
15245 Shady Grove Road
Suite 470
Rockville, MD 20850
Website: http://www.regenerx.com/wt/home/index
Phone: 301-208 9191
Email: info@regenerx.com
RegeneRx Biopharmaceuticals, Inc. RGNXW
RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company focused on tissue protection, repair and regeneration with an extensive portfolio of product candidates for first-in-class therapeutic peptides.
RegeneRx Biopharmaceuticals, Inc. RGNXW
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0000707511
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1995
Employees Not Available
Company Officers/Contacts
J.J. Finkelstein President, CEO
C. Neil Lyons CFO
Albert Rosenfeld Secretary
Company Directors
Not Available
Company Notes
Formerly=Alpha 1 Biomedicals, Inc. until 12-00
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
RegeneRx Biopharmaceuticals, Inc. RGNXW
RGNXW Security Details Other Company Securities
Share Structure
Market Value1 $115,000 a/o Aug 30, 2013
Shares Outstanding 11,500,000 a/o May 17, 2010
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders
Shareholders of Record 4,400 a/o Mar 31, 2010
Short Selling Data
Short Interest 0 (-100%)
Sep 30, 2011
Significant Failures to Deliver No
Transfer Agent(s)
RegeneRx Biopharmaceuticals, Inc. RGNXW Recent News
Jun 24, 2013 RegeneRx Releases Results of Phase 2 Clinical Trial on Patients with Epidermolysis Bullosa
RegeneRx Biopharmaceuticals, Inc. RGNXW Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 1,343 1,512 850 -
Cost of Revenue - - - -
Gross Profit 1,343 1,512 850 -
Operating Expenses
Research and Development 1,162 5,067 2,708 3,725
Sales, General and Admin. 1,022 2,456 3,174 2,782
Non-Recurring Items - - - -
Other - - - -
Operating Income (841) (6,012) (5,032) (6,506)
Income From Continuing Operations
Add'l Income/Expense Items - 4 8 12
Earnings Before Interest and Tax (841) (6,007) (5,024) (6,494)
Interest Expense 6 - - -
Earnings Before Tax (847) (6,007) (5,024) (6,494)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (847) (6,007) (5,024) (6,494)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (847) (6,007) (5,024) (6,494)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (847) (6,007) (5,024) (6,494)
RGNXW RegeneRx Biopharmaceuticals, Inc. Research DD Guide
RGNXW RegeneRx Biopharmaceuticals, Inc. Stock Message Board http://investorshangout.com/search?q=RGNXW&am...mp;yt0=Go!
RGNXW RegeneRx Biopharmaceuticals, Inc. Stock Quote http://www.otcmarkets.com/stock/RGNXW/quote
RGNXW RegeneRx Biopharmaceuticals, Inc. Stock Chart http://www.otcmarkets.com/stock/RGNXW/chart
RGNXW RegeneRx Biopharmaceuticals, Inc. Company Info http://www.otcmarkets.com/stock/RGNXW/company-info
RGNXW RegeneRx Biopharmaceuticals, Inc. Recent News http://www.otcmarkets.com/stock/RGNXW/news
RGNXW RegeneRx Biopharmaceuticals, Inc. Financials http://www.otcmarkets.com/stock/RGNXW/financials
RGNXW RegeneRx Biopharmaceuticals, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/RGNXW/filings
RGNXW RegeneRx Biopharmaceuticals, Inc. Short Sales http://www.otcmarkets.com/stock/RGNXW/short-sales
RGNXW RegeneRx Biopharmaceuticals, Inc. Insider Disclosure http://www.otcmarkets.com/stock/RGNXW/insider-transactions
RGNXW RegeneRx Biopharmaceuticals, Inc. Research Reports http://www.otcmarkets.com/stock/RGNXW/research
RGNXW RegeneRx Biopharmaceuticals, Inc. Summary http://finance.yahoo.com/q?s=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=RGNXW+Historical+Prices
RGNXW RegeneRx Biopharmaceuticals, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=RGNXW+Basic+Chart
RGNXW RegeneRx Biopharmaceuticals, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=RGNXW+Basic+Tech.+Analysis
RGNXW RegeneRx Biopharmaceuticals, Inc. Headlines http://finance.yahoo.com/q/h?s=RGNXW+Headlines
RGNXW RegeneRx Biopharmaceuticals, Inc. Press Releases http://finance.yahoo.com/q/p?s=RGNXW+Press+Releases
RGNXW RegeneRx Biopharmaceuticals, Inc. Company Profile http://finance.yahoo.com/q/pr?s=RGNXW+Profile
RGNXW RegeneRx Biopharmaceuticals, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=RGNXW+Key+Statistics
RGNXW RegeneRx Biopharmaceuticals, Inc. Industry http://finance.yahoo.com/q/in?s=RGNXW+Industry
RGNXW RegeneRx Biopharmaceuticals, Inc. Major Holders http://finance.yahoo.com/q/mh?s=RGNXW+Major+Holders
RGNXW RegeneRx Biopharmaceuticals, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=RGNXW+Insider+Transactions
RGNXW RegeneRx Biopharmaceuticals, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=RGNXW+Insider+Roster
RGNXW RegeneRx Biopharmaceuticals, Inc. Income Statement http://finance.yahoo.com/q/is?s=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=RGNXW+Cash+Flow&annual
RGNXW RegeneRx Biopharmaceuticals, Inc. Nasdaq http://www.nasdaq.com/symbol/RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Market Watch http://www.marketwatch.com/investing/stock/RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Bloomberg http://www.bloomberg.com/quote/RGNXW:US
RGNXW RegeneRx Biopharmaceuticals, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Bussinessweek http://investing.businessweek.com/research/st...cker=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Barchart http://www.barchart.com/quotes/stocks/RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. OTC Short Report http://otcshortreport.com/index.php?index=RGNXW
RGNXW RegeneRx Biopharmaceuticals, Inc. Investopedia http://www.investopedia.com/markets/stocks/RGNXW/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
(0)
(0)
